Inventor
RUETH MATTHIAS
DE16 patents
⚠️ This page may combine multiple inventors who share the name “RUETH MATTHIAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
12 patentsUS7462639B2Dec 9, 2008
Aminopyrazole derivatives
HOFFMANN LA ROCHE46 citations91
US11091541B2Aug 17, 2021
Human FcRn-binding modified antibodies and methods of use
HOFFMANN LA ROCHE6 citations84
US7226923B2Jun 5, 2007
Phthalazinone derivatives
HOFFMANN LA ROCHE8 citations70
US7405231B2Jul 29, 2008
Oxidized thioether derivatives
HOFFMANN LA ROCHE2 citations62
US7247649B2Jul 24, 2007
Oxazoles, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE3 citations62
US7235574B2Jun 26, 2007
Pentafluorosulfanyl compounds
HOFFMANN LA ROCHE6 citations62
US7259262B2Aug 21, 2007
Arylazole derivatives, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE1 citations51
US7205325B2Apr 17, 2007
Oxazole derivatives
HOFFMANN LA ROCHE1 citations51
US7205326B2Apr 17, 2007
Aniline derivatives, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE1 citations51
US7285569B2Oct 23, 2007
Tricycles, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE0 citations49
US7342030B2Mar 11, 2008
Indole derivatives
HOFFMANN LA ROCHE0 citations40
US7179812B2Feb 20, 2007
Diazine derivatives
HOFFMANN LA ROCHE0 citations39
ROCHE GLYCART AG
2 patentsUS9695233B2Jul 4, 2017
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
ROCHE GLYCART AG44 citations97
US10683345B2Jun 16, 2020
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
ROCHE GLYCART AG5 citations72